Skip to main content
Scott Cousins, MD, Ophthalmology, Durham, NC

Scott Cousins MD

Retinal Disease


Professor, Ophthalmology, Duke University School of Medicine

Join to View Full Profile
  • 2100 Erwin RdDurham, NC 27705

  • Phone+1 919-684-8111

Dr. Cousins is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • University of Miami/Jackson Health System/Bascom Palmer Eye Institute
    University of Miami/Jackson Health System/Bascom Palmer Eye InstituteResidency, Ophthalmology, 1986 - 1987
  • Washington University/B-JH/SLCH Consortium
    Washington University/B-JH/SLCH ConsortiumResidency, Ophthalmology, 1983 - 1986
  • The MetroHealth System/Case Western Reserve University
    The MetroHealth System/Case Western Reserve UniversityInternship, Internal Medicine, 1982 - 1983
  • Case Western Reserve University School of Medicine
    Case Western Reserve University School of MedicineClass of 1982

Certifications & Licensure

  • NC State Medical License
    NC State Medical License 2005 - 2025
  • VA State Medical License
    VA State Medical License 2005 - 2022
  • FL State Medical License
    FL State Medical License 1989 - 2021
  • Ophthalmology
    American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
  • Fellow (FAAO) American Academy of Ophthalmology

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • Ophthalmology Update 2013/Midwest Uveitis Society Meeting 
    Washington University School of Medicine, Saint Louis, Missouri - 3/16/2013

Press Mentions

  • 8 Questions with Dr. Moshfeghi
    8 Questions with Dr. MoshfeghiFebruary 16th, 2017
  • Stealth BioTheraputics Begins Phase I ReCLAIM Study of Elamipretide to Treat AMD
    Stealth BioTheraputics Begins Phase I ReCLAIM Study of Elamipretide to Treat AMDNovember 16th, 2016

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: